RareCan
RareCan aims to accelerate research and ultimately improve treatments and outcomes for people with rare cancers.
8 employees · est. 2019 · United Kingdom
SpringWorks Therapeutics is the older company (2019 vs 2017); SpringWorks Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | RareCan | SpringWorks Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2017 older |
| Headquarters | ||
| Headquarters | United Kingdom | Stamford, United States |
| Employees | ||
| Employees | 8 | 372 larger |
| Industry | ||
| Industry | Biotechnology, Health Care | Biopharma, Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Equity Crowdfunding | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $576.88K | $1.02B |
| Funding Rounds | ||
| Funding Rounds | 3 | 5 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Rare Cancers, Clinical Trials, Patient Recruitment, Research Acceleration, Bio-samples, Genetic Data, NHS Trusts, Patient Organizations, Cancer Research, Data Access, Treatment Outcomes, Precision Cohort, Histology-independent Trials, Life Sciences Companies, Global Research Network | Biopharmaceutical, Precision Medicine, Rare Diseases, Cancer, Oncology, Pipeline, Clinical Trials, Targeted Therapy, Genetically Defined Cancers |
| Website | ||
| Website | rarecan.com | springworkstx.com |
About RareCan
RareCan is a United Kingdom-based biotechnology and healthcare company, founded in 2019, with a mission to accelerate research and improve treatments for individuals with rare cancers. The company has recently secured a £374.88K Equity Crowdfunding investment on 15 June 2022 through Crowdcube. Rare...
About SpringWorks Therapeutics
SpringWorks Therapeutics is a commercial-stage biopharmaceutical company that utilizes a precision medicine approach to develop and deliver life-changing medicines for individuals grappling with severe rare diseases and cancer. Founded in 2017, the company boasts a diversified targeted oncology pipe...
We will tell you when either one moves
BounceWatch watches RareCan and SpringWorks Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at RareCan and SpringWorks Therapeuti... — by email.
Frequently Asked Questions
Compare RareCan with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at RareCan on 12 Sep 2024, and SpringWorks Therapeutics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.